{
 "PrintNo":"A2823","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-01-25T16:49:34.099848Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-01-25","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":504,"Name":"Felix Ortiz","Short":"ORTIZ"}],
 "Title":"Relates to requiring baseline and periodic and/or targeting drug testing to be utilized by clinicians prescribing prescription narcotic drugs",
 "Summary":"Requires baseline and periodic and/or targeting drug testing to be utilized by clinicians prescribing prescription narcotic drugs.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3331, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring baseline and periodic and/or targeting drug testing to be utilized by clinicians prescribing prescription narcotic drugs",
 "PreviousVersions":["A6336-2015","A3301-2017"]
}